Глава 5. АНТИГИСТАМИННЫЕ ЛЕКАРСТВЕННЫЕ СРЕДСТВА

Immunol. 1997. Vol. 78, № 2. P. 183-6.

12. Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome // J Matern Fetal Neonatal Med. 2002. Vol. 11, № 3. P. 146-52.

13. Aerius [product monograph] Montreal, QC: Schering-Plough Canada Inc., 2006.

14. Weber-Schoendorfer C., Schaefer C. The safety of cetirizine during pregnancy. A prospective observational cohort study // Reprod Toxicol. 2008. Vol. 26, № 1. P. 19-23. Epub 2008 May 13.

15. Lis-Swiety A.D., Brzezinska-Wcislo L.A. The safety of the antihistamines in dermatoses of pregnancy // Wiad Lek. 2006. Vol. 59. P. 89-91.

16. Gilboa S.M., Strickland M.J., Olshan A.F., Werler M.M., Correa A. Use of anti-histamine medications during early pregnancy and isolated major malformations // Birth Defects Res A Clin Mol Teratol. 2009. Vol. 85. P. 137-50.

17. Kallen B. Use of antihistamine drugs in early pregnancy and delivery outcome // J Matern Fetal Neonatal Med. 2002. Vol. 11. P. 146-52.

18. Schatz M. H1-antihistamines in pregnancy and lactation // Clin Allergy Immunol. 2002. Vol. 17. P. 421-36.

19. Allegra (product monograph). Laval, QC: Sanofi-Aventis Canada Inc., 2006.

20. Kallen B., Olausson P.O. Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? // Int J Risk Saf Med. 2001.

Vol. 14. P. 115-9.

21. Pedersen L., Norgaard M., Skriver M.V., Olsen J., Sorensen H.T. Prenatal exposure to loratadine in children with hypospadias: a nested case-control study within the Danish National Birth Cohort // Am J Ther. 2006. P. 13. P. 320-4.

22. Gilbert C., Mazzotta P., Loebstein R., Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review // Drug Saf. 2005. Vol. 28, № 8. P. 707-19.

23. Gilboa S.M., Strickland M.J., Olshan A.F., Werler M.M., Correa A., National Birth Defects Prevention Study Use of antihistamine medications during early pregnancy and isolated major malformations // Birth Defects Res A Clin Mol Teratol. 2009. Vol. 85, № 2. P. 137-50.

24. Diav-Citrin O., Shechtman S., Aharonovich A., Moerman L., Arnon J., Wajnberg R., et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled study // J Allergy Clin Immunol. 2003.

Vol. 111. P. 1239-43.

25. Centers for Disease Control and Prevention (CDC). Evaluation of an association between loratadine and hypospadias United States, 1997-2001 // MMWR Morb Mortal Wkly Rep. 2004. Vol. 53. P. 219-221.

26. Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome // J Matern Fetal Neonatal Med. 2002. Vol. 11, № 3. P. 146-152.

27. Diav-Citrin O., Shechtman S., Aharonovich A., Moerman L., Arnon J., Wajnberg R., et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled study // J Allergy Clin Immunol. 2003.

Vol. 111, № 6. P. 1239-1243.

28. NAEPP Report of the Working Group on Asthma and Pregnancy: Management of Asthma During Pregnancy. NIH Publication No. 93-3279. Bethesda, MD: U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; 1993. [Accessed May 11, 2011]. Asthma and Pregnancy Report.

29. Rindi V. La eliminazione degli antistaminici di sintesi con il latte e l'azione latto-goga de questi // Riv Ital Ginecol. 1951. Vol. 34. P. 147-157.

30. Findlay J.W., Butz R.F., Sailstad J.M., Warren J.T., Welch R.M. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers // Br J Clin Pharmacol. 1984. Vol. 18, № 6. P. 901-906.